ResearchMoz

North America Caprolactam Industry Outlook to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants

GlobalData
Published Date » 2012-03-27
No. Of Pages » 98


GlobalDatas report, North America Caprolactam Industry Outlook to 2016 Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of North America Caprolactam industry. The research presents major market trends affecting Caprolactam in the region. It provides capacity growth and presents installed capacity by key feedstock, process and technology. In addition, it presents market size, demand and production forecasts, end use demand forecasts, and company shares of major Caprolactam producers in the region. The research also provides price trends and trade balance data. Supply and demand scenario for key countries within the region is also included in the report. Overall, the reports present a comprehensive analysis of the specific petrochemical in the region covering all the major parameters.

Scope

  • Caprolactam industry supply scenario in the region from 2000 to 2016 consisting of capacity growth, installed plant capacity by key feedstock, production process and technology 
  • Supply and demand outlook in key countries in North America from 2000 to 2016
  • Information of all active and planned Caprolactam plants in North America with capacity forecasts to 2016
  • Detailed information on all operating and planned projects covering details such as process, technology, key feedstock and operator and equity details
  • Caprolactam industry market dynamics in North America from 2000 to 2016 consisting of market size, demand and production outlook, demand by end use sector, and average prices
  • Key countries trade balance data from 2000 to 2016 including details on imports, exports, net exports and imports as percentage of demand
  • Comparison of supply demand scenario in North America with other regions in the world
  • Company snapshots including company overview, business description and information on the current and upcoming Caprolactam plants in North America 
  • Company shares of key competitors in North America and across major countries in the region
Reasons to buy

  • Obtain the most up to date information available on the Caprolactam industry in North America
  • Benefit from GlobalDatas advanced insight on the Caprolactam industry in North America
  • Identify the macro and micro-economic trends affecting the Caprolactam industry in North America
  • Understand the market positioning of Caprolactam producers in North America
  • Develop market-entry and market expansion strategies 
  • Benchmark your operations and strategies against the major companies in North America
Table of Content

1 Table of Contents
1.1 List of Tables 
1.2 List of Figures 

2 Introduction
2.1 GlobalData Report Guidance 

3 North America Caprolactam Industry
3.1 North America Caprolactam Industry, Supply Scenario, 2000-2016 
3.1.1 North America Caprolactam Industry, Total Plant Capacity, 2000-2016 
3.1.2 North America Caprolactam Industry, Installed Plant Capacity by Key Feedstock, 2011 
3.1.3 North America Caprolactam Industry, Installed Plant Capacity by Production Process, 2011 
3.1.4 North America Caprolactam Industry, Installed Plant Capacity by Technology, 2011 
3.1.5 North America Caprolactam Industry, Company Share, 2011 
3.2 North America Caprolactam Industry, Market Dynamics, 2000-2016 
3.2.1 North America Caprolactam Industry, Market Size, 2000-2016 
3.2.2 North America Caprolactam Industry, Demand and Production Outlook, 2000-2016 
3.2.3 North America Caprolactam Industry, Demand by End Use Sector, 2011 
3.2.4 North America Caprolactam Industry, Price Forecasts, 2000-2016 

4 The US Caprolactam Industry
4.1 The US Caprolactam Industry, Supply Scenario, 2000-2016 
4.1.1 The US Caprolactam Industry, Total Plant Capacity, 2000-2016 
4.1.2 The US Caprolactam Industry, Installed Plant Capacity by Key Feedstock, 2011 
4.1.3 The US Caprolactam Industry, Installed Plant Capacity by Production Process, 2011 
4.1.4 The US Caprolactam Industry, Installed Plant Capacity by Technology, 2011 
4.1.5 The US Caprolactam Industry, Company Share, 2011 
4.2 The US Caprolactam Industry, Market Dynamics, 2000-2016 
4.2.1 The US Caprolactam Industry, Market Size, 2000-2016 
4.2.2 The US Caprolactam Industry, Demand and Production Outlook, 2000-2016 
4.2.3 The US Caprolactam Industry, Demand by End Use Sector, 2011 
4.2.4 The US Caprolactam Industry, Price Forecasts, 2000-2016 
4.3 The US Caprolactam Industry, Trade Balance, 2000-2016 
4.3.1 The US Caprolactam Industry, Imports and Exports, 2000-2016 
4.3.2 The US Caprolactam Industry, Net Exports, 2000-2016 
4.3.3 The US Caprolactam Industry, Imports as Percentage of Demand, 2000-2016 

5 Honeywell International Inc., Company Snapshot
5.1 Honeywell International Inc., Company Overview 
5.2 Honeywell International Inc., Key Information 
5.3 Honeywell International Inc., Business Description 
5.3.1 Business Overview 
5.4 Honeywell International Inc., Caprolactam Market, 2011 
5.4.1 Honeywell International Inc., Caprolactam Capacity Split, North America and Rest of the World, 2011 
5.4.2 Honeywell International Inc., Caprolactam Plant Capacity Share in North America, 2011 
5.4.3 Honeywell International Inc., Caprolactam Capacity in North America, 2000-2016 
5.4.4 Honeywell International Inc., Caprolactam Plant Details in North America, 2011 
5.5 SWOT Analysis 
5.5.1 Overview 
5.5.2 Honeywell International Inc. Strengths 
5.5.3 Honeywell International Inc. Weaknesses 
5.5.4 Honeywell International Inc. Opportunities 
5.5.5 Honeywell International Inc. Threats 

6 BASF SE, Company Snapshot
6.1 BASF SE, Company Overview 
6.2 BASF SE, Key Information 
6.3 BASF SE, Business Description 
6.3.1 Business Overview 
6.4 BASF SE, Caprolactam Market, 2011 
6.4.1 BASF SE, Caprolactam Capacity Split, North America and Rest of the World, 2011 
6.4.2 BASF SE, Caprolactam Plant Capacity Share in North America, 2011 
6.4.3 BASF SE, Caprolactam Capacity in North America, 2000-2016 
6.4.4 BASF SE, Caprolactam Plant Details in North America, 2011 
6.5 SWOT Analysis 
6.5.1 Overview 
6.5.2 BASF SE Strengths 
6.5.3 BASF SE Weaknesses 
6.5.4 BASF SE Opportunities 
6.5.5 BASF SE Threats 

7 Royal DSM N.V., Company Snapshot
7.1 Royal DSM N.V., Company Overview 
7.2 Royal DSM N.V., Key Information 
7.3 Royal DSM N.V., Business Description 
7.3.1 Business Overview 
7.3.2 Nutrition 
7.3.3 Other Activities 
7.3.4 Performance Materials 
7.3.5 Pharma 
7.3.6 Polymer Intermediates 
7.4 Royal DSM N.V., Caprolactam Market, 2011 
7.4.1 Royal DSM N.V., Caprolactam Capacity Split, North America and Rest of the World, 2011 
7.4.2 Royal DSM N.V., Caprolactam Plant Capacity Share in North America, 2011 
7.4.3 Royal DSM N.V., Caprolactam Capacity in North America, 2000-2016 
7.4.4 Royal DSM N.V., Caprolactam Plant Details in North America, 2011 
7.5 SWOT Analysis 
7.5.1 Overview 
7.5.2 Royal DSM N.V. Strengths 
7.5.3 Royal DSM N.V. Weaknesses 
7.5.4 Royal DSM N.V. Opportunities 
7.5.5 Royal DSM N.V. Threats 

8 Appendix
8.1 Definitions 
8.1.1 Installed Plant Capacity 
8.1.2 Key Feedstock 
8.1.3 Process 
8.1.4 Technology 
8.2 Abbreviations 
8.3 GlobalData’s Methodology 
8.3.1 Coverage 
8.3.2 Secondary Research 
8.3.3 Primary Research 
8.3.4 Expert Panel Validation 
8.4 Contact Us 
8.5 Disclaimer 

List of Tables


Table 1: North America, Total Caprolactam Plant Capacity, MMTPA, 2000-2016 10
Table 2: Caprolactam Industry, Total Plant Capacity by Region, MMTPA, 2000-2016 11
Table 3: North America, Caprolactam Plants Capacity, MMTPA, 2000-2016 12
Table 4: North America, Active Caprolactam Plants Details, MMTPA, 2011 13
Table 5: North America, Active Caprolactam Plants by Key Feedstock, Process and Technology, 2011 13
Table 6: North America, Top Caprolactam Plants Capacity, %, 2011 14
Table 7: North America, Top Caprolactam Plants Details, 2011 14
Table 8: North America , Caprolactam Industry, Installed Plant Capacity by Key Feedstock, %, 2011 15
Table 9: North America, Caprolactam Industry, Installed Plant Capacity by Naphtha, 2011 16
Table 10: North America, Caprolactam Industry, Installed Plant Capacity by Natural gas, 2011 16
Table 11: North America , Caprolactam Industry, Installed Plant Capacity by Production Process , %, 2011 17
Table 12: North America, Caprolactam Industry, Installed Plant Capacity by Conventional Cyclohexanone, 2011 18
Table 13: North America, Caprolactam Industry, Installed Plant Capacity by Hydrogenation of Adiponitrile, 2011 18
Table 14: North America, Caprolactam Industry, Installed Plant Capacity by Hydroxylamine Phosphate Oxime, 2011 18
Table 15: North America , Caprolactam Industry, Installed Plant Capacity by Technology , %, 2011 19
Table 16: North America, Caprolactam Industry, Installed Plant Capacity by Honeywell Caprolactam Technology, 2011 20
Table 17: North America, Caprolactam Industry, Installed Plant Capacity by BASF-DuPont Caprolactam Technology, 2011 20
Table 18: North America, Caprolactam Industry, Installed Plant Capacity by DSM Caprolactam Technology, 2011 20
Table 19: North America, Caprolactam Industry, Installed Plant Capacity by Company, %, 2011 21
Table 20: North America, Caprolactam Industry, Demand Value, $bn, 2000-2016 23
Table 21: Caprolactam Industry, Demand Value Growth by Region, $bn, 2000-2016 24
Table 22: North America, Caprolactam Industry, Demand and Production, MMTPA, 2000-2016 26
Table 23: Caprolactam Industry, Demand by Region, MMTPA, 2000-2016 27
Table 24: Caprolactam Industry, Production by Region, MMTPA, 2000-2016 28
Table 25: North America, Caprolactam Industry, Demand by Country, %, 2011 29
Table 26: North America, Caprolactam Industry, Demand by End Use Sector, %, 2011 30
Table 27: Caprolactam Industry, End Use by Regions, MMTPA, 2011-2016 31
Table 28: North America, Caprolactam Industry, Price Forecasts, $/Tonne, 2000-2016 33
Table 29: Caprolactam Industry, Average Price by Region, $/Tonne, 2000-2016 34
Table 30: The US, Total Caprolactam Plant Capacity, MMTPA, 2000-2016 36
Table 31: The US, Caprolactam Plants Capacity, MMTPA, 2000-2016 36
Table 32: The US, Active Caprolactam Plants by State, %, 2011 37
Table 33: The US, Active Caprolactam Plants Details, MMTPA, 2011 38
Table 34: The US, Active Caprolactam Plants by Key Feedstock, Process and Technology, 2011 38
Table 35: The US, Top Caprolactam Plants Capacity, %, 2011 39
Table 36: The US, Top Caprolactam Plants Details, 2011 39
Table 37: The US, Caprolactam Industry, Installed Plant Capacity by Key Feedstock, %, 2011 40
Table 38: The US, Caprolactam Industry, Installed Plant Capacity by Naphtha, 2011 41
Table 39: The US, Caprolactam Industry, Installed Plant Capacity by Natural gas, 2011 41
Table 40: The US, Caprolactam Industry, Installed Plant Capacity by Production Process , %, 2011 42
Table 41: The US, Caprolactam Industry, Installed Plant Capacity by Conventional Cyclohexanone, 2011 43
Table 42: The US, Caprolactam Industry, Installed Plant Capacity by Hydrogenation of Adiponitrile, 2011 43
Table 43: The US, Caprolactam Industry, Installed Plant Capacity by Hydroxylamine Phosphate Oxime, 2011 43
Table 44: The US, Caprolactam Industry, Installed Plant Capacity by Technology , %, 2011 44
Table 45: The US, Caprolactam Industry, Installed Plant Capacity by Honeywell Caprolactam Technology, 2011 45
Table 46: The US, Caprolactam Industry, Installed Plant Capacity by BASF-DuPont Caprolactam Technology, 2011 45
Table 47: The US, Caprolactam Industry, Installed Plant Capacity by DSM Caprolactam Technology, 2011 45
Table 48: The US, Caprolactam Industry, Installed Plant Capacity by Company, %, 2011 46
Table 49: The US, Caprolactam Industry, Demand Value, $bn, 2000-2016 48
Table 50: The US, Caprolactam Industry, Demand and Production, MMTPA, 2000-2016 50
Table 51: The US, Caprolactam Industry, Demand by End Use Sector, %, 2011 51
Table 52: The US, Caprolactam Industry, Price Forecasts, 2000-2016 53
Table 53: The US, Caprolactam Industry, Imports and Exports, MMTPA, 2000-2016 55
Table 54: The US, Caprolactam Industry, Net Exports, MMTPA, 2000-2016 57
Table 55: The US, Caprolactam Industry, Imports as Percentage of Demand, %, 2000-2016 59
Table 56: Honeywell International Inc., Key Facts 60
Table 57: North America, Honeywell International Inc., Caprolactam Capacity Share, %, 2011 63
Table 58: North America, Honeywell International Inc., Caprolactam Plant Capacity, MMTPA, 2000-2016 64
Table 59: North America, Honeywell International Inc. Caprolactam Plants Details, 2011 64
Table 60: Honeywell International Inc., SWOT Analysis 65
Table 61: BASF SE, Key Facts 70
Table 62: BASF SE,Caprolactam Capacity Split, North America and Rest of the World,%, 2011 73
Table 63: North America, BASF SE, Caprolactam Capacity Share, %, 2011 74
Table 64: North America, BASF SE, Caprolactam Plant Capacity, MMTPA, 2000-2016 75
Table 65: North America, BASF SE Caprolactam Plants Details, 2011 75
Table 66: BASF SE, SWOT Analysis 76
Table 67: Royal DSM N.V., Key Facts 82
Table 68: Royal DSM N.V.,Caprolactam Capacity Split, North America and Rest of the World,%, 2011 86
Table 69: North America, Royal DSM N.V., Caprolactam Capacity Share, %, 2011 87
Table 70: North America, Royal DSM N.V., Caprolactam Plant Capacity, MMTPA, 2000-2016 88
Table 71: North America, Royal DSM N.V. Caprolactam Plants Details, 2011 88
Table 72: Royal DSM N.V., SWOT Analysis 89

List of Figures


Figure 1: North America, Total Caprolactam Plant Capacity, MMTPA, 2000-2016 9
Figure 2: Caprolactam Industry, Global Plant Capacity by Region, MMTPA, 2000-2016 11
Figure 3: North America, Top Caprolactam Plants Capacity, %, 2011 13
Figure 4: North America, Caprolactam Industry, Installed Plant Capacity by Key Feedstock, %, 2011 15
Figure 5: North America, Caprolactam Industry, Installed Plant Capacity by Production Process, %, 2011 17
Figure 6: North America, Caprolactam Industry, Installed Plant Capacity by Technology, %, 2011 19
Figure 7: North America, Caprolactam Industry, Installed Plant Capacity by Company, %, 2011 21
Figure 8: North America, Caprolactam Industry, Demand Value, $bn, 2000-2016 22
Figure 9: Caprolactam Industry, Demand Value Growth by Region, $bn, 2000-2016 24
Figure 10: North America, Caprolactam Industry, Demand and Production, MMTPA, 2000-2016 25
Figure 11: Caprolactam Industry, Demand by Region, MMTPA, 2000-2016 27
Figure 12: Caprolactam Industry, Production by Region, MMTPA, 2000-2016 28
Figure 13: North America, Caprolactam Industry, Demand by Country, %, 2011 29
Figure 14: North America, Caprolactam Industry, Demand by End Use Sector, %, 2011 30
Figure 15: Caprolactam Industry, End Use by Regions, MMTPA, 2011-2016 31
Figure 16: North America, Caprolactam Industry, Price Forecasts, $/Tonne, 2000-2016 32
Figure 17: Caprolactam Industry, Average Price by Geography, $/Tonne, 2000-2016 34
Figure 18: The US, Total Caprolactam Plant Capacity, MMTPA, 2000-2016 35
Figure 19: The US, Active Caprolactam Plants by State, %, 2011 37
Figure 20: The US, Top Caprolactam Plants Capacity, %, 2011 38
Figure 21: The US, Caprolactam Industry, Installed Plant Capacity by Key Feedstock, %, 2011 40
Figure 22: The US, Caprolactam Industry, Installed Plant Capacity by Production Process, %, 2011 42
Figure 23: The US, Caprolactam Industry, Installed Plant Capacity by Technology, %, 2011 44
Figure 24: The US, Caprolactam Industry, Installed Plant Capacity by Company, %, 2011 46
Figure 25: The US, Caprolactam Industry, Demand Value, $bn, 2000-2016 47
Figure 26: The US, Caprolactam Industry, Demand and Production, MMTPA, 2000-2016 49
Figure 27: The US, Caprolactam Industry, Demand by End Use Sector, %, 2011 51
Figure 28: The US, Caprolactam Industry, Price Forecasts, $/Tonne, 2000-2016 52
Figure 29: The US, Caprolactam Industry, Imports and Exports, MMTPA, 2000-2016 54
Figure 30: The US, Caprolactam Industry, Net Exports, MMTPA, 2000-2016 56
Figure 31: The US, Caprolactam Industry, Imports as Percentage of Demand, %, 2000-2016 58
Figure 32: North America, Honeywell International Inc.,Caprolactam Capacity Share, %, 2010 63
Figure 33: BASF SE, Caprolactam Capacity Split, North America and Rest of the World,%, 2011 73
Figure 34: North America, BASF SE,Caprolactam Capacity Share, %, 2011 74
Figure 35: Royal DSM N.V., Caprolactam Capacity Split, North America and Rest of the World,%, 2011 86
Figure 36: North America, Royal DSM N.V.,Caprolactam Capacity Share, %, 2011 87

Upcoming Reports:

Depression Drug Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The market is expected to exhibit high growth in developed economies such as the U.S. and Europe over the forecast period. The rapid increase in the number of patients suffering from depression is expected to be one of the main driving forces for the estimated growth, which can be attributed to elevating stress levels, unhealthy lifestyle, and social imbalances. In the U.S. and Europe, various regulations pertaining to drug approval and patents, as well as commercial issues, such as restriction on the sale of antidepressants without prescription are the major restraints which are...
Immunoassay Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Immunoassays refer to biochemical tests or analytical techniques used to measure concentration of macromolecules in a solution with the help of antibody or immunoglobulin. The macromolecules refer to the analytes or proteins. These analytical methods are based on formation of antigen-antibody complex resultant of specific immuno reactions. Immunoassay techniques are specially suited for effective analysis of the compounds at low concentrations even at nanogram and picogram concentrations. High reliability, high sensitivity, applicability to diverse range of compounds, distinctive...
Lyophilization Equipment and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Lyophilization is a process in which water is removed from a frozen product and placed in vacuum which allows the ice to directly convert into vapor. In this process ice is directly converted in vapor phase without undergoing liquid phase.  This process includes three phases namely freezing, sublimation and desorption. Many products such as biotechnologically derived, anti-infective and in vitro diagnostics are manufactured through lyophilization process. Anti infective products include semi synthetic penicillin, cephalosporin, erythromycin, doxycycline and chloramphenicol which...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...
Ontarios thanks Sustainable Development Technology Canada for Clean Tech Ecosystem Movements
Apr 8, 2014  
Sustainable Development Technology Canada has leveraged an extra $2.2 billion in funding from project partners that also includes global clean technology companies.  Sustainable Development Technology Canada (SDTC) is energizing and evolving the development and demonstration of a clean technology ecosystem. They are the vital contributors to the prominent concentration of clean...